...
【24h】

Tumour virus epidemiology

机译:肿瘤病毒流行病学

获取原文
获取原文并翻译 | 示例

摘要

A viral etiology of cancer was first demonstrated in 1911 by Peyton Rous who injected cell-free filtrate from a chicken sarcoma into healthy chickens and found it induced a tumour. Since the discovery over 50 years ago of the Epstein-Barr virus as the cause of Burkitt lymphoma, seven other human viruses or groups of viruses-hepatitis B virus, hepatitis C virus, human immunodeficiency virus type 1, some human papillomaviruses, human T-cell lymphotropic virus type 1, Kaposi sarcoma-associated herpesvirus and Merkel cell polyomavirus-have been linked to human cancer. Collectively, these eight viruses cause over 20 different types of cancer and contribute to 10-12% of all cancer, with a greater burden in low-and middle-income countries. For many viruses, immunosuppression greatly increases the risks of persistent infection, development of chronic sequelae and cancer. Although several viruses share similar routes of transmission (especially sexual activity, injection drug use and mother-to-child transmission), the predominant route of transmission varies across viruses, and for the same virus can vary by geographical location. In general, vulnerable populations at the greatest risk for viral infections and their associated diseases include people, especially children, living in low-to middle-income countries, men who have sex with men, people who use injection drugs and female sex workers.
机译:首先在1911年通过Peyton rous将无细胞滤液注射到健康的鸡中的Peyton Rous,并发现它诱导肿瘤。自从50年前的Epstein-Barr病毒作为Burkitt淋巴瘤的原因,七种其他人类病毒或病毒 - 乙型肝炎病毒,丙型肝炎病毒,人类免疫缺陷病毒类型1,一些人乳头瘤病毒,人类T-细胞淋巴细胞病毒类型1,Kaposi肉瘤相关的Herpesvirus和Merkel Cell Polyomavirus-已与人类癌症有关。总的来说,这八种病毒导致20种不同类型的癌症,促成了所有癌症的10-12%,在低收入中等收入中有更大的负担。对于许多病毒,免疫抑制大大增加了持续感染的风险,慢性后遗症和癌症的发育。虽然几种病毒共享类似的传输途径(特别是性活动,注射药物使用和母婴传输),但是主要的传动途径在病毒中变化,并且对于相同的病毒可以通过地理位置而变化。一般来说,病毒感染风险最大的弱势群体以及他们的相关疾病的风险包括人,特别是儿童,生活在低到中等收入国家,与男性发生性关系的人,使用注射毒品和女性性工作者的人。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号